- Obesity and Breast Cancer: The Role of Crown-Like Structures in Breast Adipose Tissue in Tumor Progression, Prognosis, and Therapy
-
Faria SS, Corrêa LH, Heyn GS, Sant'Ana LPd, Almeida RdN, Magalhães KG
- KMID: 2511776
- J Breast Cancer.
- 2020 Jun;23(3):233-245.
- doi: 10.4048/jbc.2020.23.e35
Obesity is associated with increased risk and aggressiveness of many types of cancer. Women with obesity and breast cancer are more likely to be diagnosed with larger and higher-grade tumors... -
- CITED
-
- Close
- SHARE
-
- Close
- Cutaneous Scalp Metastases of Malignant Phyllodes Tumor of the Breast
-
Lee Hj, Lim HS, Ki SY, Lee JE, Lee JS, Park MH
- KMID: 2511790
- J Breast Cancer.
- 2020 Jun;23(3):320-325.
- doi: 10.4048/jbc.2020.23.e18
Phyllodes tumor (PT) of the breast is a relatively rare fibroepithelial tumor that accounts for < 1% of primary breast neoplasms. PT is classified histologically as benign, borderline, or malignant,... -
- CITED
-
- Close
- SHARE
-
- Close
- Coronary Event Analysis in Breast Cancer Patients Who Received Breast-Conserving Surgery and PostOperative Radiotherapy: a Korean Nationwide Cohort Study
-
Sung SY, Lee JH, Yang KH, Seo Y, Kang MY
- KMID: 2511785
- J Breast Cancer.
- 2020 Jun;23(3):291-302.
- doi: 10.4048/jbc.2020.23.e30
Purpose: Adjuvant breast radiotherapy (RT) following breast-conserving surgery (BCS) has been reported to induce cardiac toxicity in breast cancer patients. We investigated the incidence and risk factors of major coronary... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Timing of GonadotropinReleasing Hormone Agonist Administration for Ovarian Protection in Patients with Breast Cancer
-
Shin JJ, Choi YM, Jun JK, Lee KH, Kim TY, Han W, Im SA
- KMID: 2511781
- J Breast Cancer.
- 2020 Jun;23(3):268-278.
- doi: 10.4048/jbc.2020.23.e33
Purpose: This study was performed to investigate the effect of the interval between the start of gonadotropin-releasing hormone agonist (GnRHa) and the start of chemotherapy on ovarian protection in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of the Predictive Role of Serum Lipid Profiles in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
-
Qu F, Chen R, Peng Y, Ye Y, Tang Z, Wang Y, Zong B, Yu H, Liu S
- KMID: 2511778
- J Breast Cancer.
- 2020 Jun;23(3):246-258.
- doi: 10.4048/jbc.2020.23.e32
Purpose: Effective predictors of the response to neoadjuvant chemotherapy (NAC) are still insufficient. This study aimed to investigate the predictive value of serum lipid profiles for the response to NAC... -
- CITED
-
- Close
- SHARE
-
- Close
- Anastomosing Hemangioma of the Breast: An Unusual Case at an Unusual Site
-
Lin MS, Ngo T, Schwartz MR, Mehta RR, Ayala AG, Ro JY
- KMID: 2511791
- J Breast Cancer.
- 2020 Jun;23(3):326-330.
- doi: 10.4048/jbc.2020.23.e15
Anastomosing hemangioma (AH) is an unusual benign vascular lesion that commonly occurs in the kidney and genitourinary tract. We report a case of AH in a 49-year-old woman presenting as... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Oncotype DX Recurrence Score on the Patterns of Locoregional Recurrence in Breast Cancer (Korean Radiation Oncology Group 19-06)
-
Kim K, Jung J, Shin KH, Kim JH, Chang JH, Kim SS, Kim H, Park W, Kim YB, Chang JS
- KMID: 2511788
- J Breast Cancer.
- 2020 Jun;23(3):314-319.
- doi: 10.4048/jbc.2020.23.e36
The current study evaluated the impact of the Oncotype DX recurrence score (RS) on the patterns of locoregional recurrence (LRR) in node-negative, hormone receptor-positive/ human epidermal growth factor receptor 2-negative... -
- CITED
-
- Close
- SHARE
-
- Close
- Relative Survival Benefit by Hormonal Receptor Status of Adding Trastuzumab to Neoadjuvant Chemotherapy in Breast Cancer Patients
-
Schneider J, Lee HJ, Nam SJ, Lee SJ, Jung JH, Jung SH, Lim ST, Jeon YW, Gwak H
- KMID: 2511779
- J Breast Cancer.
- 2020 Jun;23(3):259-267.
- doi: 10.4048/jbc.2020.23.e34
Purpose: Neoadjuvant chemotherapy (NAC) involving trastuzumab markedly increases pathologic complete response (pCR) rates in patients with human epidermal growth factor receptor 2-positive (HER2+) breast cancer. Despite increasing pCR rates, long-term... -
- CITED
-
- Close
- SHARE
-
- Close
- Identifying Long-Term Survival Candidates among Patients with Isolated Locoregionally Recurrent Breast Cancer: Implications of the Use of Systemic Chemotherapy
-
Kim BH, Shin KH, Chie EK, Kim JH, Kim K, Hwang KT, Kim J, Choi IS, Park JH, Kim S
- KMID: 2511783
- J Breast Cancer.
- 2020 Jun;23(3):279-290.
- doi: 10.4048/jbc.2020.23.e31
Purpose: We aimed to investigate the clinicopathologic factors associated with distant metastasis (DM) and post-recurrence overall survival (OS) after salvage treatments for isolated locoregional recurrence (ILRR) of breast cancer and... -
- CITED
-
- Close
- SHARE
-
- Close
- Concordance of Programmed DeathLigand 1 Expression between SP142 and 22C3/SP263 Assays in Triple-Negative Breast Cancer
-
Lee SE, Park HY, Lim SD, Han HS, Yoo YB, Kim WS
- KMID: 2511786
- J Breast Cancer.
- 2020 Jun;23(3):303-313.
- doi: 10.4048/jbc.2020.23.e37
Purpose: Triple-negative breast cancer (TNBC) represents a major clinical challenge due to its aggressive and metastatic behavior and the lack of available targeted therapies. Therefore, therapeutic strategies are needed to... -
- CITED
-
- Close
- SHARE
-
- Close
